ArticleAnnals of surgical oncology2026
Validation of Lymph Node Thresholds as Prognostic Factors in Medullary Thyroid Cancer Staging.
Article in Annals of surgical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThe current AJCC medullary thyroid cancer (MTC) staging system anatomically stratifies lymph node (LN) status but does not incorporate quantitative assessment of LN metastases. Our past work identified ≥ 8 positive LNs and LN ratio (LNR) ≥ 14% as associated with significantly increased MTC-specific mortality. In this study, we 1) validate these thresholds using the NCDB and 2) compare them to the current AJCC staging system.
methodsIn this retrospective cohort study, patients with MTC were abstracted from NCDB (2004-2020). Chi-square and Fisher's exact tests compared categorical variables, and t-tests continuous variables. Overall survival (OS) was estimated with Kaplan-Meier and log-rank testing. Cox Proportional hazards models estimated the association of LN thresholds with OS after adjusting for covariates.
resultsThere were 5685 patients (median age: 55 years; 56.4% female; 74.3% non-Hispanic White). The 5-year OS was 78.2% (95% confidence interval [CI] 76.4-79.9) for LNR ≥ 14% and 93.9% (95% CI 92.9-94.8) for LNR < 14%. For ≥ 8 positive LNs, 5-year OS was 77.2% (95% CI 74.8-79.4) versus 90.4% (95% CI 89.4-91.4) for < 8. After adjustment, LNR ≥ 14% was associated with a 44% increased mortality risk (hazard ratio [HR] 1.44, 95% CI 1.10-1.88, p = 0.008); ≥ 8 positive LNs conferred a 37% increased hazard (HR 1.37, 95% CI 1.13-1.66, p = 0.001). Neither AJCC N-stage nor nodal status was associated with a significant adjusted hazard difference.
conclusionsPreviously identified prognostic LN thresholds for MTC were valid in the NCDB. A LNR ≥ 14% and ≥ 8 positive LNs provide better prognostic discrimination than the current AJCC system and aid refinement of the current MTC staging system.
Indexed as
Identifiers
41807837What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.